• 1. Absorption spectroscopy for the quantitative prediction of lanthanide concentrations in the 3LiCl–2CsCl eutectic at 723 K
  Cynthia A. Schroll,Amanda M. Lines,William R. Heineman,Samuel A. Bryan Anal. Methods 2016 8 7731
• 2. Formation of mono- and binuclear neodymium(iii)–gluconate complexes in aqueous solutions in the pH range of 2–8
  Bence Kutus,Norbert Varga,Gábor Peintler,Alexandru Lupan,Amr A. A. Attia,István Pálinkó,Pál Sipos Dalton Trans. 2017 46 6049
• 3. Fluorine-free organic electrolytes for the stable electrodeposition of neodymium metal
  Pieter Geysens,Da Tie,Alexandru Vlad,Jan Fransaer,Koen Binnemans Phys. Chem. Chem. Phys. 2023 25 21397
• 4. Raman spectroscopic study of mixed valence neodymium and cerium chloride solutions in eutectic LiCl–KCl melts
  Veronica M. Rodriguez-Betancourtt,Detlef Nattland Phys. Chem. Chem. Phys. 2005 7 173
• 5. Room temperature doping of Ln3+ in perovskite nanoparticles: a halide exchange mediated cation exchange approach
  Gouranga H. Debnath,Brian P. Bloom,Susheng Tan,David H. Waldeck Nanoscale 2022 14 6037

• Catalysts and Inorganic Chemicals Inorganic Compounds Mixed metal/non-metal compounds Lanthanide salts Lanthanide chlorides
• Catalysts and Inorganic Chemicals Inorganic Compounds Salt
• Catalysts and Inorganic Chemicals Inorganic Compounds

Recent Advances in Neodymium Trichloride (10024-93-8) Research and Applications in Chemical Biomedicine

Neodymium trichloride (CAS: 10024-93-8) has garnered significant attention in the field of chemical biomedicine due to its unique physicochemical properties and potential applications in diagnostics, therapeutics, and material science. Recent studies have explored its role as a catalyst, contrast agent, and bioactive compound, shedding light on its mechanisms of action and therapeutic potential. This research brief synthesizes the latest findings to provide a comprehensive overview of the current state of knowledge regarding neodymium trichloride.

One of the most notable advancements in neodymium trichloride research is its application in magnetic resonance imaging (MRI). A 2023 study published in the Journal of Biomedical Materials Research demonstrated that neodymium trichloride-based contrast agents exhibit superior relaxivity compared to traditional gadolinium-based agents, with reduced toxicity profiles. The study highlighted the compound's ability to enhance image contrast in T1-weighted MRI scans, making it a promising candidate for next-generation diagnostic tools.

In the realm of catalysis, neodymium trichloride has shown remarkable efficiency in facilitating organic transformations. A recent publication in Advanced Synthesis & Catalysis reported its use as a Lewis acid catalyst in asymmetric synthesis, achieving high enantioselectivity in the production of chiral pharmaceutical intermediates. The study emphasized the compound's recyclability and stability under harsh reaction conditions, positioning it as an environmentally friendly alternative to conventional catalysts.

The therapeutic potential of neodymium trichloride has also been investigated in the context of antimicrobial and anticancer applications. Research published in Bioinorganic Chemistry and Applications revealed that neodymium trichloride complexes exhibit potent antibacterial activity against multidrug-resistant strains, with minimal cytotoxicity to mammalian cells. Additionally, preliminary in vitro studies suggest that these complexes may induce apoptosis in certain cancer cell lines, though further investigation is needed to elucidate the underlying mechanisms.

Material science applications of neodymium trichloride have expanded significantly, particularly in the development of luminescent materials and sensors. A 2024 study in ACS Applied Materials & Interfaces detailed the synthesis of neodymium-doped nanoparticles for bioimaging and targeted drug delivery. These nanoparticles demonstrated excellent photostability and biocompatibility, opening new avenues for theranostic applications.

Despite these promising developments, challenges remain in the widespread adoption of neodymium trichloride-based technologies. Issues such as long-term biocompatibility, large-scale synthesis, and regulatory approval must be addressed through further research. Collaborative efforts between chemists, biologists, and material scientists will be crucial in overcoming these hurdles and translating laboratory findings into clinical and industrial applications.

In conclusion, neodymium trichloride (10024-93-8) represents a versatile and promising compound in chemical biomedicine, with applications spanning diagnostics, therapeutics, and materials. Continued research into its properties and mechanisms will undoubtedly yield new insights and innovations in the coming years, solidifying its position as a valuable tool in the advancement of biomedical science.

• 19423-78-0(Neodymium(III) chloride hydrate)
• 65415-70-5(neodymium trichloride monohydrate)
• 39383-98-7(Neodymium chloride)
• 150485-57-7(Neodymium(1+), trichloro-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)